[THE INVESTOR] On Sept. 13, LabGen (084650) increased 0.76% from the previous day to 13,300 won (US$11.88). It had declined 13.27% through the past month. Standard deviation, the risk index for stock price, was 2.2% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of LabGen was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -6.0%. As high volatility and a bearish stock price trend, the return-on-risk was poor, compared with its peer group. However, the return-on-risk is much better than the industrial mean, -8.0, and thus the industrial comparison performance was good.

- Compared with its peer group, in spite of high Volatility, Earning Rate is low - Related stocks mixed, Other Service industry +0.84% - Institutions and Individuals buy, Foreigners sell - Turnover Rate and Price Range both proper - The main shareholding group is Individuals

While Institutions have been buying LabGen during the past three trading days, foreigners have been selling during the past three trading days. As a shareholding sum by investor group for the past four weeks, institutions have bought 17,168 shares with trending trade and individuals have bought 4,541 shares lessening its position. However, during the same period, foreigners have sold 21,709 shares.

Cumulated shareholdings per investor group (1Mo)		Total shareholdings per investor group

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.